- Home
- THAR vs PAPL Comparison
THAR vs PAPL Comparison
Compare THAR & PAPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- PAPL
- Stock Information
- Founded
- THAR 2017
- PAPL 2015
- Country
- THAR United States
- PAPL Canada
- Employees
- THAR N/A
- PAPL N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- PAPL Finance: Consumer Services
- Sector
- THAR Health Care
- PAPL Finance
- Exchange
- THAR Nasdaq
- PAPL Nasdaq
- Market Cap
- THAR 4.0M
- PAPL 3.9M
- IPO Year
- THAR 2022
- PAPL 2023
- Fundamental
- Price
- THAR $2.03
- PAPL $0.45
- Analyst Decision
- THAR Strong Buy
- PAPL Strong Buy
- Analyst Count
- THAR 1
- PAPL 2
- Target Price
- THAR $17.00
- PAPL $5.25
- AVG Volume (30 Days)
- THAR 47.8K
- PAPL 132.5K
- Earning Date
- THAR 11-07-2024
- PAPL 01-31-2025
- Dividend Yield
- THAR N/A
- PAPL N/A
- EPS Growth
- THAR N/A
- PAPL N/A
- EPS
- THAR N/A
- PAPL N/A
- Revenue
- THAR N/A
- PAPL $2,688,987.00
- Revenue This Year
- THAR N/A
- PAPL $22.61
- Revenue Next Year
- THAR N/A
- PAPL $30.00
- P/E Ratio
- THAR N/A
- PAPL N/A
- Revenue Growth
- THAR N/A
- PAPL 7.46
- 52 Week Low
- THAR $1.84
- PAPL $0.41
- 52 Week High
- THAR $7.71
- PAPL $2.14
- Technical
- Relative Strength Index (RSI)
- THAR 45.25
- PAPL 44.70
- Support Level
- THAR $1.86
- PAPL $0.43
- Resistance Level
- THAR $2.06
- PAPL $0.48
- Average True Range (ATR)
- THAR 0.11
- PAPL 0.05
- MACD
- THAR -0.00
- PAPL -0.00
- Stochastic Oscillator
- THAR 38.64
- PAPL 19.38
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About PAPL Pineapple Financial Inc.
Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. Through its data-driven systems together with cloud-based tools, it offers advantages in the Canadian mortgage industry relative to alternative mortgage broker arrangements and also provides back office services.